<DOC>
	<DOCNO>NCT01894373</DOCNO>
	<brief_summary>determine therapeutic role CIK cell patient psoriasis</brief_summary>
	<brief_title>Autologous Cytokine Induced Killer Cells ( CIK ) Patients With Severe Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Have ever physician 's diagnosis chronic moderate severe plaque psoriasis candidate treatment CIK Are treat initiate CIK therapy time enrollment Be able provide write informed consent Be willing able fully participate duration patient followup ( 5 year ) PUVA Grenz ray therapy within 4 week prior randomisation . UVB therapy within 2 week prior randomisation . Systemic treatment biological therapy ( market otherwise ) possible effect psoriasis ( e.g. , alefacept , efalizumab , etanercept , infliximab ) within 3 month prior randomisation . Systemic treatment biologicals possible effect psoriasis ( e.g. , corticosteroid , vitamin D analogue , retinoids , hydroxycarbamide , azathioprine , methotrexate , cyclosporine , immunosuppressant ) within 4 week prior randomisation . Any topical treatment scalp ( except medicate shampoos emollient ) within 2 week prior randomisation ( medicated shampoos/emollients allow doubleblind phase ) . Shampoos contain corticosteroid , e.g . Clobex® , allow within 2 week prior randomisation . Planned use topical treatment psoriasis trunk limb , besides study medication , study exception : • emollient • medication use treat psoriasis skin fold and/or genitals ( medication may use purpose apart Class 15 corticosteroid . Topical treatment face Class 15 corticosteroid within 2 week prior randomisation . Planned initiation , change , concomitant medication could affect psoriasis ( e.g. , beta blocker , antimalaria drug , lithium ) doubleblind phase study . Treatment nonmarketed drug substance ( i.e. , agent yet make available clinical use follow registration ) within 4 week prior randomisation . Planned use chemical treatment hair ( eg relaxer , 'perms ' , colouring ) doubleblind phase study . Current diagnosis erythrodermic , exfoliative pustular psoriasis . Patients follow condition also present psoriatic area scalp trunk/limbs : viral ( e.g . herpes varicella ) lesion skin , fungal bacterial skin infection , parasitic infection , skin manifestation relation tuberculosis syphilis , rosacea , acne rosacea , acne vulgaris , atrophic skin , stria atrophicae , fragility skin vein , ichthyosis , ulcer wound . Other inflammatory skin disease may confound evaluation psoriasis scalp trunk/limbs .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>